5.71
-0.05 (-0.87%)
| Previous Close | 5.76 |
| Volume | 4,977,191 |
| Price / Earnings (Forward) | 7.78 |
| Price / Sales | 0.230 |
| Price / Book | 0.550 |
| 52 Weeks Range |
| Profit Margin | 2.63% |
| Operating Margin (TTM) | 3.63% |
| Diluted EPS (TTM) | 0.580 |
| Quarterly Revenue Growth (YOY) | -1.80% |
| Quarterly Earnings Growth (YOY) | 39.00% |
| Total Debt/Equity (MRQ) | 133.64% |
| Current Ratio (MRQ) | 1.29 |
| Operating Cash Flow (TTM) | 588.33 M |
| Levered Free Cash Flow (TTM) | 154.64 M |
| Return on Assets (TTM) | 3.82% |
| Return on Equity (TTM) | 5.90% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | AdaptHealth Corp. | Mixed | Bearish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | 1.5 |
| Price Volatility | 3.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -0.5 |
| Average | 2.00 |
|
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company operates under four reportable segments that align with its product categories: (i) Sleep Health, (ii) Respiratory Health, (iii) Diabetes Health, and (iv) Wellness at Home. The company generates majority of its revenue from the Sleep Health segment. The Sleep Health segment provides sleep therapy equipment, supplies and related services (including continuous positive airway pressure and BiLevel services) to individuals for the treatment of obstructive sleep apnea. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Value |
| % Held by Insiders | 8.16% |
| % Held by Institutions | 102.35% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Oep Capital Advisors, L.P. | 30 Jun 2026 | 16,312,698 |
| Skyknight Capital, L.P. | 30 Jun 2026 | 8,580,443 |
| Iron Triangle Partners Lp | 31 Dec 2025 | 2,609,003 |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| CURRIE HARRISS T | 5.70 | - | 141,372 | 805,820 |
| Aggregate Net Quantity | 141,372 | |||
| Aggregate Net Value ($) | 805,820 | |||
| Aggregate Avg. Buy ($) | 5.70 | |||
| Aggregate Avg. Sell ($) | - | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| CURRIE HARRISS T | Officer | 09 Sep 2026 | Acquired (+) | 141,372 | 5.70 | 805,820 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |